[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:mild-cognitive-disorder:p-tau217":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Mild cognitive disorder","p-tau217",3,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07236190","Biomarker-based Trial of NPC-1 for Alzheimer's Pathology",[12],"Phase 2","RECRUITING","2026-08-26T02:18:05.435729Z","2026-07-05T05:32:16.676716Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07667478","NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE",[],"2026-08-26T02:17:39.048487Z","2026-07-05T03:45:20.370664Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07701161","Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device",[],"2026-08-26T02:18:32.765187Z","2026-07-19T19:36:05.083304Z"]